Erythrasma is a skin condition that affects the skin, usually in the groin, armpits, or between the toes. It is a bacterial infection that causes a red, scaly rash. It is often misdiagnosed as a fungal infection, which can lead to unnecessary treatment and prolonged suffering. In this article, we will discuss the causes, symptoms, diagnosis, and treatment of erythrasma. We will also provide tips on how to prevent and manage the condition.
Erythrasma is a bacterial infection of the skin caused by the Corynebacterium minutissimum bacteria. It usually affects the groin, armpits, or between the toes. It is characterized by a red, scaly rash that can be itchy or painful. It is most common in people who are overweight or who have diabetes. It is also more common in people with a weakened immune system.
Erythrasma is caused by the Corynebacterium minutissimum bacteria. This bacteria is normally found on the skin, but in some cases, it can overgrow and cause an infection. Factors that can increase the risk of erythrasma include: • Being overweight • Having diabetes • Having a weakened immune system • Poor hygiene • Wearing tight, non-breathable clothing • Living in a warm, humid climate
The main symptom of erythrasma is a red, scaly rash. The rash typically appears in the groin, armpits, or between the toes. It may also appear on other areas of the body, such as the abdomen, chest, or back. Other symptoms of erythrasma include itching, burning, and pain.
Erythrasma is usually diagnosed based on the appearance of the rash. Your doctor may also take a sample of the rash and examine it under a microscope. This is done to rule out other possible causes of the rash, such as a fungal infection.
Erythrasma is usually treated with antibiotics. These antibiotics can be taken orally or applied topically. In some cases, your doctor may recommend a combination of both. Treatment usually lasts for several weeks.
Erythrasma can be prevented by practicing good hygiene, wearing loose-fitting, breathable clothing, and avoiding hot, humid climates. If you have erythrasma, it is important to keep the area clean and dry. Avoiding tight clothing and using an antifungal powder can also help manage the condition.
Erythrasma is a bacterial infection of the skin that is often misdiagnosed as a fungal infection. It is characterized by a red, scaly rash that can be itchy or painful. The condition is caused by the Corynebacterium minutissimum bacteria and is more common in people who are overweight or have diabetes. Treatment usually involves antibiotics, and prevention involves practicing good hygiene and wearing loose-fitting clothing. If you have erythrasma, it is important to keep the area clean and dry and avoid tight clothing. With the right treatment and prevention measures, you can manage erythrasma and reduce your risk of recurrence.
1.
Study recommends new grading system for invasive squamous cell carcinoma of the lung
2.
Bayer is transforming pharmaceutical research into women's health
3.
Ineffective medication can remove the "worst fear" of schizophrenia.
4.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
5.
A healthier lifestyle after bowel screening shown to prevent bowel cancer
1.
Oncology Partnerships: Driving Innovation Through Strategic Collaborations and Pharma Engagement USA
2.
Beyond the Tumor: Emerging Frontiers in Cancer Systems Biology
3.
Everything You Need To Know About Splenic Infarction – Symptoms, Treatments, And Prevention
4.
Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation
5.
Understanding Leiomyoma: Causes, Symptoms, and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
2.
Updates on Standard V/S High Risk Myeloma Treatment
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Should We Use DARA Up Front As First-Line Therapy in MM? - Part II
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation